TriReme Medical, Inc., a Pleasanton, California and Singapore-based provider of innovative solutions for complex lesions, has closed a new round of financing.
The company did not reveal the amount of the funding but it is known that has now raised US$18m to date.
The round was led by Luminor Capital of Singapore, with participation from major existing investors and new Asian investors.
The company intends to use the capital to continue to develop its pipeline of dilatation catheters and expand its commercial infrastructure worldwide.
Led by Eitan Konstantino, Ph.D., President and CEO, and John Borrell, Vice President of Sales, TriReme Medical is a medical device company focused on developing, manufacturing, and commercializing innovative percutaneous devices for the treatment of complex coronary and peripheral arterial disease.
The company is focused on the US and the emerging Asian markets.